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Objective: To determine whether obesity, physical ﬁtness, and physical activity
parameters are associated with the enzymatic activity of serum dipeptidyl
peptidase IV (sDPPIV) in a sample of healthy women and men.
Design and methods: We have correlated parameters of obesity, physical ﬁtness,
and physical activity with sDPPIV activity in 374 healthy subjects (age: 60.7 
6.9 years, body mass index: 26.1  4.1 kg/m2). Enzymatic activity was analyzed
using spectroﬂuorimetry, body composition was assessed by impedanciometry,
physical ﬁtness data were obtained using the Senior Fitness Test, and physical.e00627
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
y-nc-nd/4.0/).
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was applied to determine the relationship between DPPIV activity and the rest of
parameters and signiﬁcantly correlated variables were introduced into linear
regression models to predict DPPIV.
Results: Serum DPPIV activity was negatively associated with obesity parameters
such as body mass (r ¼ 0.112), body mass index (BMI) (r ¼ 0.147), waist
circumference (r ¼ 0.164), waist-to-hip ratio (0.104), and percentage of fat
mass (r ¼ 0.185). Serum DPPIV activity was positively associated with
cardiovascular ﬁtness (r ¼ 0.138), total amount of physical activity (r ¼ 0.153),
and time spent doing light exercise (r ¼ 0.184). Regression models revealed sex
diﬀerences in enzyme activity with overall activity higher in women than in men
(b ¼ 0.437, p < 0.001). Further, percent fat mass was an independent negative
predictor of DPPIV activity (b ¼ 0.184, p ¼ 0.001). Serum DPPIV activity
was positively predicted based on the amount of time spent doing light physical
activity (b ¼ 0.167, p ¼ 0.001).
Conclusion: Our results demonstrate that sDPPIV activity is positively associated
with healthier parameters regarding fatness, ﬁtness and physical activity.
Keywords: Metabolism, Physiology, Endocrinology
1. Introduction
Dipeptidyl-peptidase IV (DPPIV) is a type II membrane-bound glycoprotein that can
be released into bodyﬂuids [1]. Themajor source of andmechanism(s) regulating circu-
lating DPPIV remain unknown [2, 3]. Almost 50 peptides (growth factors, hormones,
and neuropeptides) have been identiﬁed as substrates for DPPIV. Its enzymatic action
can generate biologically active peptides from precursors, convert active peptides to
diﬀerent receptor speciﬁcity, or inactivate peptides [4]. This enzyme plays known roles
in immune function [5], controlling satiety in the hypothalamus [6], regulating insulin
release, and controlling glucose homeostasis [7]. In addition, serum DPPIV (sDPPIV)
has endocrine eﬀects [8] on inﬂammation and cardiovascular regulation [9].
Indeed, DPPIV is expressed in adipocytes and may impair insulin sensitivity directly
in fat tissue and in skeletal and smooth muscle cells [2]. Serum DPPIV levels are
negatively associated with the accumulation of visceral fat and the presence of meta-
bolic syndrome in men with type 2 diabetes [10]. However, it is unclear how DPPIV
activity transitions from being a healthy modulator of a variety of important physi-
ological mechanisms to an enzyme associated with pathological conditions. Some
studies suggest that high DPPIV levels are associated with the development of
obesity, while others show that lower DPPIV activity is related to increased fat
mass [3]. Yet, the majority of studies conducted thus far have involved small sample
sizes of obese subjects [1, 2, 10, 11, 12, 13].on.2018.e00627
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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between skeletal muscle, adipose tissues, and organs such as liver; in particular, this
crosstalk involves communication viamyokines regarding the energy demands of active
muscle [14]. A myokine function has been proposed for DPPIV in which its endocrine
role could be related to exercise response; indeed, some authors have hypothesized that
DPPIV decreases following exercise [11]. Physical activity, thought to positively inﬂu-
ence energy balance by increasing energy expenditure, has positive eﬀects on skeletal
muscle metabolism and insulin sensitivity [15]. Exercise training is also well known
to improve physical ﬁtness and to combat chronic diseases and aging associated disor-
ders [16], however, it is controversial whether physical ﬁtness or physical activity are the
best predictors of individual health [17]. Further, the relative and joint contributions of
fatness, ﬁtness, and physical activity to health remain poorly understood [18].
Sex diﬀerences play a role in the link between obesity and metabolic syndrome and
cardiovascular diseases [19]. The associations between hypertension [20] and car-
diovascular risk [21] with serum peptidase activity, including DPPIV [22], have
been found to diﬀer depending on sex [20, 21, 22] and age [20, 21]. Therefore,
the inﬂuence of sex in the relationship between DPPIV and cardiovascular risk fac-
tors cannot be ruled out.
Given the interaction between physical activity/ﬁtness and obesity, and the role of
DPPIV as a myokine, we sought to determine whether obesity, physical ﬁtness,
and physical activity parameters are associated with the enzymatic activity of
sDPPIV in a sample of healthy women and men.2. Methodology
2.1. Participants
Participants in this study comprised 374 healthy volunteer individuals recruited to
participate in a Project about Alzheimer’s Disease in Gipuzkoa, Spain (GAP). Par-
ticipants had no history of cardiovascular, proliferative, or central nervous system
degenerative disease. The average age was 60  6.9 years (209 females, 60.1 
7.0 years; 165 males, 60.1  7.0 years). All participants underwent thorough med-
ical examination and were excluded if they presented chronic pathologies involving
drug treatment, such as estrogen replacement therapy, hormonal contraceptives or
testosterone, or any other signiﬁcant neurologic, systemic, or psychiatric disorder
that could cause cognitive impairment, as well as women who were pregnant or
breastfeeding.
All participants were informed of the extent of the study and signed an informed con-
sent document approved by the Ethical and Scientiﬁc Committees (CEIC Euskadi
PGA-2).on.2018.e00627
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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Blood samples (10 mL) were collected by venipuncture into heparinized tubes after
fasting overnight. Following centrifugation (1500 rpm, 10 min), 0.5 mL serum sam-
ples were separated and stored frozen at 80 C until DPPIV enzyme activity
analysis.2.3. Dipeptidyl peptidase IV enzyme activity
Dipeptidyl peptidase IV (EC 3.4.14.5) activity in serum samples was measured by
spectroﬂuorimetry in a microplate reader ﬂuorometer FLUOstar OPTIMA (BMG
Labtech). All samples were analyzed in triplicate and incubated at 37 C in micro-
plates for 30 min. Each well contained 10 mL of serum and 190 mL of assay buﬀer
(Tris-HCl 50 mM, 2 mM H-Gly-Pro-b-naftilamide (Bachem) pH 8.3). Blanks and
controls were also included in each plate.
The incubation time was based on preliminary assays to assess the linearity of the
reaction over time as well as protein content. When introduced into the ﬂuorimeter,
speciﬁc excitation (340 nm) and emission (410 nm) ﬁlters were selected. The
enzyme activity was expressed as units of enzyme activity per milliliter of serum
(U/mL). One unit of activity is the amount of enzyme required to release 1 pmol
of ﬂuorescent product per minute. Speciﬁc inhibition assays in the presence of Di-
protin A 2 mM (Bachem) were performed to ensure appropriate measurement of
DPPIV activity.2.4. Anthropometric measurement
Body mass (kg), height (cm) were measured using height boards, weighing scales
(A~no Sayol SL, Barcelona, Spain). Waist and hip circumference (cm) were measured
with a non-elastic anthropometric tape measure to the nearest 0.1 cm. The body mass
and height of the participants were then used to calculate body mass index (BMI) in
kg/m2. All measurements were taken by the same person following the standards of
the International Society for the Advancement of Kinanthropometry [23]. Body
composition (percent of muscle mass, percent of fat mass, and percent of fat-free
mass) were determined using a bioimpedance meter (InBody 230, InBody Co. Ltd.).2.5. Measurement of physical ﬁtness data
Physical ﬁtness was measured using the Senior Fitness Test (SFT) battery, which is
designed to assess physical parameters associated with diﬀerent components of phys-
ical ﬁtness [24]. For lower body and upper body ﬂexibility assessment, Chair Sit-
&-Reach and Back Scratch tests were performed. Muscle strength was determined
using Chair Stand and Arm Curl tests for lower and upper limbs, respectively.on.2018.e00627
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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was used and cardiorespiratory ﬁtness was assessedwith the 6-minWalk test (6MWT).2.6. Measurement of physical activity
To accurately measure physical activity data, we used accelerometers that record
active and sedentary periods during everyday life. Accelerometers oﬀer a number
of desirable features for monitoring human movement: amount, duration, frequency,
and intensity of movement [25]. Accelerometry was performed using the Actigraph
GT3X model (Actigraph LLC). The monitor was worn on the hip with a belt for a
seven-day period; participants were asked to remove it only for sleeping and bathing.
Data ﬁles recorded on the accelerometers were downloaded and processed using Ac-
tilife software (version 5, Actigraph, 2011). Only days in which the monitors were
worn for ten or more hours were considered valid, and at least three days of data were
required to validate the recorded data [26]. Non-wear time was deﬁned by an interval
of at least 60 consecutive minutes of zero activity intensity counts, with tolerance for
2 min of counts between 0 and 50. The summary variables presented in this analysis
are as follows: number of steps per day, mean counts per minute (CPM), and number
of minutes per day spent in intensity-speciﬁc categories. Sedentary time was deﬁned
as all activity below 100 CPM. The classiﬁcation developed by Freedson [27] was
followed for the rest of the cut-oﬀ points to classify physical activity as light
(100e1951 CPM), moderate (1952e5724 CPM), or vigorous (5725 CPM). Mod-
erate to Vigorous Physical Activity (MVPA) was viewed as the sum of minutes
spent in moderate and vigorous physical activity (1952 CPM).2.7. Statistical analysis
All statistical analyses were performed using the Statistical Package for the Social
Sciences (SPSS Inc., version 24, IBM). A normality test was performed (Kolmo-
gorov-Smirnov) for all the variables analyzed, for all participants, and for female
and male groups. Depending on the normality of the dependent variable, the diﬀer-
ences between groups were compared using the Student’s t-test or ManneWhitney
U test, respectively, to analyze sex diﬀerences. The data are presented as mean 
standard deviation (SD).
Pearson’s partial correlation analysis, with age and diabetes medication status (and
sex when the whole group was analyzed) as the control variables, was carried out to
determine the relationship between DPPIV activity and the rest of the parameters.
When raw results did not show a normal distribution, the normality of their log or
square root was analyzed. If data were not normally distributed, they were ranked
to perform partial correlations. The results are presented as Pearson’s correlation
coeﬃcient (r). The diﬀerences were considered to be statistically signiﬁcant when
p < 0.05.on.2018.e00627
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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DPPIV serum activity were introduced into linear regression models to ﬁnd the in-
dependent positive or negative association of the variable with enzymatic activity.
Backward selection was used to select the models that best explained the variability
of the dependent variables.3. Results
3.1. Sex diﬀerences
Mean sDPPIV activity, age, anthropometric characteristics, physical ﬁtness, and
physical activity data for all participants, as well as separately for men and women,
are described in Table 1. A Student’s t-test or Mann-Whitney U test were applied to
analyze sex-related diﬀerences (signiﬁcance p < 0.05).
Serum DPPIV activity was signiﬁcantly higher in women than in men (p < 0.001).
Body mass, height, BMI, waist circumference, percent of muscle mass, and percent
of fat-free mass were higher in men than in women. However, percent of fat mass
was higher for women than men and there were no signiﬁcant sex-dependent diﬀer-
ences in age or waist-to-hip ratio.
Upper and lower limb ﬂexibility was higher for women (p < 0.001 both). However,
men showed better arm strength (p ¼ 0.014) and walked farther in the six-minute
walk test (p < 0.001).
The most signiﬁcant diﬀerence between sexes was found in the amount of time
spent in vigorous activity; men scored signiﬁcantly higher in this area than women
(p ¼ 0.007). However, women spent signiﬁcantly more time doing light activities
during the day (p ¼ 0.041).3.2. Correlations
Serum DPPIV activity was assessed for correlation with anthropometric parameters
(Table 2). Pearson’s coeﬃcient showed a negative correlation between enzyme
activity and body mass (r ¼ 0.112, p ¼ 0.032), BMI (r ¼ 0.147, p ¼ 0.005),
waist circumference (r ¼ 0.164, p ¼ 0.002), waist-to-hip ratio (r ¼ 0.104,
p ¼ 0.046), and percent of fat mass (r ¼ 0.185, p < 0.001) in all participants.
The same signiﬁcant correlations were found in men (body mass, r ¼ 0.188,
p ¼ 0.017; BMI, r ¼ 0.195, p ¼ 0.013; waist circumference, r ¼ 0.206,
p ¼ 0.009; waist-to-hip ratio, r ¼ 0.172, p ¼ 0.030; percent of fat mass,
r ¼ 0.211, p ¼ 0.007). In women, the only correlation with sDPPIV was found
when the percent of fat mass was analyzed, which was negatively correlated with
enzyme activity (r ¼ 0.160, p ¼ 0.023).on.2018.e00627
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Table 1. Anthropometric characteristics, physical ﬁtness, and physical activity
among healthy individuals (mean  SD).
Variables All subjects Women Men p
Mean ± SD n Mean ± SD n Mean ± SD n
sDPPIV (UP/mL) 33739  7180 369 36085  6950 206 30773  6335 163 <0.001t
Anthropometric characteristics
Age (years) 60.7  6.9 373 60.1  7.0 209 61.4  6.8 164 0.068U
Body mass (kg) 71.7  14.0 374 64.3  10.6 209 81.3  11.8 165 <0.001t
Height (cm) 165.5  8.4 374 160.4  6.0 209 172.0  6.3 165 <0.001U
BMI (kg/m2) 26.1  4.1 374 25.0  4.1 209 27.5  3.7 165 <0.001t
Waist circumference
(cm)
92.5  11.2 373 88.3  10.3 208 97.9  9.9 165 <0.001t
Waist-to-hip ratio 0.95  0.05 373 0.95  0.05 209 0.94  0.04 165 0.121U
Muscular mass (%) 27.3  6.1 374 22.8  2.8 209 33.2  3.9 165 <0.001U
Fat mass (%) 30.6  8.1 374 33.5  7,9 209 26,8  6,7 165 <0.001t
Fat-free mass (%) 49.5  10.1 374 42.1  4.7 209 58.9  6.6 165 <0.001U
Physical ﬁtness data
Chair Sit-&-Reach
(cm þ/)
0.36  10.8 367 3.31  9.5 205 3.38  11.3 162 <0.001U
Back Scratch (cm þ/) 1.02  8.9 360 1.80  6.7 201 4.59  10.1 159 <0.001U
Chair stand (stands) 16.2  4.5 368 15.9  4.2 205 16.55  4.9 163 0.248U
Arm Curl (reps) 16.7  4.6 368 16.1  4.3 205 17.38  4.8 163 0.014U
8-Ft Up-&-Go (s) 7.02  1.5 368 6.94  1.3 204 7.13  1.8 164 0.215U
6-Min Walk (m) 578.4  86.0 366 560.5  76.1 204 600.9  92.5 162 <0.001U
Physical activity data
CPM 741.5  221.6 332 731.3  195.9 188 754.8  251.4 144 0.740U
Steps/day 10315  3594 332 10150  3349 188 10530  3892 144 0.632U
Sedentary (min/day) 503.3  82.8 332 501.12  75.9 188 506.3  91.3 144 0.425U
Light (min/day) 275.8  70.3 332 281.7  71.6 188 268.1  68.1 144 0.041U
Moderate (min/day) 55.1  28.8 332 52.6  27.1 188 58.3  30.7 144 0.191U
Vigorous (min/day) 2.35  8.2 332 1.19  3.1 188 4.00  12.6 144 0.007U
MVPA (min/day) 57.6  31.2 332 53.8  27.9 188 62.5  34.5 144 0.064U
sDPPIV ¼ Serum dipeptidyl peptidase IV; BMI ¼ body mass index; CPM ¼ counts per min.; MVPA ¼
moderate to vigorous physical activity, (t)Student’s t-test, (U)Mann-Whitney test.
Bold values indicate p<0.05.
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of the participants. In all participants (r¼ 0.138, p¼ 0.009), as well as when women
(r¼ 0.144, p¼ 0.041) and men (r¼ 0.181, p¼ 0.023) were analyzed separately, sig-
niﬁcant positive correlations were found between enzyme activity and 6MWT scores.
Positive associations between physical activity data (Table 4) and sDPPIV activity
were found with CPM (r ¼ 0.153, p ¼ 0.006) and the time spent in light intensity
physical activity (r¼ 0.184, p¼ 0.001), in all participants. In women, the correlationon.2018.e00627
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Table 2. Pearson’s correlation coeﬃcients (r) between anthropometric charac-
teristics and sDPPIV enzymatic activity.
Variable Partial correlation
All subjects(a) Women(b) Men(c)
r p r p r p
Body mass (kg) L0.112 0.032 0.050 0.480 L0.188 0.017
Height (cm) 0.056 0.284 0.103 0.149 0.046 0.574
BMI (kg/m2) L0.147 0.005 0.096 0.170 L0.195 0.013
Waist circumference (cm) L0.164 0.002 0.114 0.106 L0.206 0.009
Waist-to-hip ratio L0.104 0.046 0.074 0.292 L0.172 0.030
Muscular mass (%) 0.048 0.359 0.135 0.053 0.049 0.536
Fat mass (%) L0.185 <0.001 L0.160 0.023 L0.211 0.007
Fat-free mass (%) 0.041 0.436 0.128 0.069 0.056 0.478
(a) Controlled by sex, age, and medication for diabetes. N ¼ 374.
(b, c) Controlled by age and medication for diabetes. (b)N ¼ 206, (c)N ¼ 163.
sDPPIV ¼ Serum dipeptidyl peptidase IV; BMI ¼ body mass index.
Bold values indicate p<0.05.
Table 3. Pearson’s correlation coeﬃcients (r) between physical ﬁtness and
sDPPIV enzymatic activity.
Variable Partial correlation
All subjects(a) Women(b) Men(c)
r p r p r p
Chair Sit-&-Reach (cm þ/) 0.083 0.115 0.024 0.739 0.106 0.186
Back Scratch (cm þ/) 0.080 0.131 0.096 0.180 0.001 0.989
Chair stand (no. of stands) 0.009 0.871 0.068 0.336 0.132 0.098
Arm Curl (no. of reps) 0.073 0.164 0.020 0.777 0.130 0.103
8-Ft Up-&-Go (s) 0.016 0.764 0.058 0.415 0,005 0.949
6-Min Walk (m) 0.138 0.009 0.144 0.041 0.181 0.023
(a) Controlled by sex, age, and medication for diabetes. N ¼ 374.
(b, c) Controlled by age and medication for diabetes. (b)N ¼ 206, (c)N ¼ 163.
sDPPIV ¼ Serum dipeptidyl peptidase IV.
Bold values indicate p<0.05.
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(r¼ 0.207, p¼ 0.005) reached statistical signiﬁcance, while in men, CPM was posi-
tively correlated with enzyme activity (r ¼ 0.167, p ¼ 0.049) and sedentary activity
was negatively correlated with DPPIV activity (r ¼ 0.178, p ¼ 0.035).3.3. Regression models
Linear regression models were built to ascertain the inﬂuence of the studied param-
eters on sDPPIV activity. Table 5 shows the regression model for the whole sample.on.2018.e00627
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Table 4. Pearson’s correlation coeﬃcients (r) between physical activity and
sDPPIV enzymatic activity.
Variable Partial correlation
All subjects(a) Women(b) Men(c)
r p r p r p
CPM 0.153 0.006 0.161 0.029 0.167 0.049
Steps/day 0.104 0.062 0.116 0.117 0.117 0.167
Sedentary (min/day) 0.101 0.170 0.037 0.618 L0.178 0.035
Light (min/day) 0.184 0.001 0.207 0.005 0.155 0.067
Moderate (min/day) 0.059 0.285 0.112 0.129 0.023 0.785
Vigorous (min/day) 0.023 0.685 0.042 0.572 0.054 0.530
MVPA (min/day) 0.088 0.115 0.118 0.111 0.059 0.491
(a) Controlled by sex, age, and medication for diabetes. N ¼ 374.
(b, c) Controlled by age and medication for diabetes. (b)N ¼ 206, (c)N ¼ 163.
sDPPIV ¼ Serum dipeptidyl peptidase IV; BMI ¼ body mass index.
CPM ¼ counts per min; MVPA ¼ moderate to vigorous physical activity.
Bold values indicate p<0.05.
Table 5. Linear regression model built with sDPPIV activity as the dependent
variable and sex, age, medication for diabetes, percent of fat mass, 6-min walk,
CPM, and light activity as independent variables.
B SE 95% conﬁdence limits Standard
coefﬁcients
(b)
t p value
Lower Upper
(Constant) 12662 4500 3808 21516 2.814 0.005
Sex 6312 805.9 4726 7897 0.437 7.832 <0.001
Age 113.9 53.29 9.14 218.8 0.110 2.139 0.033
% fat mass 163.0 49.7 260.9 65.16 0.184 3.277 0.001
Light activity 564.1 169.7 230.1 898.1 0.167 3.323 0.001
ANOVA R2: 0.186; p < 0.001.
B: Non-standarized coeﬃcient; SE: standard error; t: t-test statistics; p value indicates the signiﬁcance of
an ANOVA checking the value of the predictive model; R2: coeﬃcient of determination.
sDPPIV ¼ Serum dipeptidyl peptidase IV; CPM ¼ counts per min.
Bold values indicate p<0.05.
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medication for diabetes, percent of fat mass, 6MWT, CPM, and time spent in light
activity as independent variables. In the model that showed the highest ﬁnal coeﬃ-
cient of determination (R2 ¼ 0.186, p < 0.001), sex, age, and minutes of light activ-
ity were positive predictors of sDPPIV activity. Interestingly, percent of fat mass
was a negative predictor of enzyme activity.
In the model built with women’s results, age, medication for diabetes, percent of fat
mass, 6MWT results, CPM, and min of light activities were included as independenton.2018.e00627
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Table 6. Linear regression model built with sDPPIV activity in women as the
dependent variable. The model includes age, medication for diabetes, percent of
fat mass, 6-min walk, CPM, and light activity as independent variables.
B SE 95% conﬁdence limits Standard
coefﬁcients
(b)
t p value
Lower Upper
(Constant) 19090 4862 9495 28684 3.926 <0.001
Age 267.1 69.9 129.2 405.1 0.270 3.821 <0.001
% fat mass 143.2 62.2 266.1 20.3 0.162 2.300 0.023
Light activity 20.2 6.82 6.78 33.7 0.207 2.967 0.003
ANOVA R2: 0.106; p < 0.001.
B: Non-standardized coeﬃcient; SE: standard error; t: t-test statistics; p value indicates the signiﬁcance of
an ANOVA checking the value of the predictive model; R2: coeﬃcient of determination.
sDPPIV ¼ Serum dipeptidyl peptidase IV; CPM ¼ counts per min.
Bold values indicate p<0.05.
Table 7. Linear regression model built with sDPPIV activity in men as the
dependent variable. The model includes age, medication for diabetes, percent of
fat mass, 6-min walk, CPM, and sedentary activity as independent variables.
B SE 95% conﬁdence limits Standard coefﬁcients
(b)
t p value
Lower Upper
(Constant) 39012 2266 34530 43494 17.210 <0.001
% fat mass 234.5 75.4 383.7 85.2 0.251 3.107 0.002
Sedentary activity 11.3 5.12 21.4 1.16 0.178 2.204 0.029
ANOVA R2: 0.082; p ¼ 0.001.
B: Non-standardized coeﬃcient; SE: standard error; t: t-test statistics; p value indicates the signiﬁcance of
an ANOVA checking the value of the predictive model; R2: coeﬃcient of determination.
sDPPIV ¼ Serum dipeptidyl peptidase IV; CPM ¼ counts per min.
Bold values indicate p<0.05.
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sDPPIV activity, while the coeﬃcient for the percent of fat mass was negative
(R2 ¼ 0.106, p < 0.001).
Finally, in men, age, medication for diabetes, percent of fat mass, 6MWT results,
CPM, and min of sedentary activity were included as independent variables
(Table 7). In the last model, percent of fat mass and time spent in sedentary activities
were found to be negative predictors of enzymatic activity (R2 ¼ 0.082, p ¼ 0.001).4. Discussion
To the best of our knowledge, there is no published work describing sDPPIV activity
and its concentration in serum as being connected to anthropometric data, physical
ﬁtness, and physical activity together. Further, most published works about DDPIV
and obesity show results related to concentration, not activity. The analysis ofon.2018.e00627
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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have shown discrepancies that conﬁrm the poorly understood function of sDPPIV
[8]. In previous works with cancer patients, the imbalance between activity and con-
centration has often been described. Thus, diﬀerent progression patterns, not only for
DPPIV, but also for other peptidases, have been described depending on the
analyzed parameter (mRNA, protein concentration, or enzyme activity), the source
of the sample (tissue or serum), or cancer type [28, 29]. Thus, it is not contradictory
to ﬁnd diﬀerent relationships between sDPPIV and obesity depending on the anal-
ysis of concentration or activity.
DPPIV is linked to adiposity and obesity, but the regulation and extent of this connec-
tion remains unclear. In a cohort of healthy individuals, we measured their anthropo-
metric characteristics and quantiﬁed several aspects of physical ﬁtness and physical
activity to determine whether these parameters were tied to DPPIV activity.
Our study has conﬁrmed the close relationship between sDPPIV activity and obesity.
Conﬂicting ﬁndings related to this association have been described [2, 3, 10, 11, 12,
13, 22]. Most authors have described a positive association between the amount of
DPPIV protein present in the serum and obesity parameters [10, 12, 13]. Accord-
ingly, some authors have reported the overexpression of DPPIV in visceral fat
from adults with obesity and metabolic syndrome and an increase in DPPIV level
along with the size of adipocytes in culture from obese adults [2]. However, sDPPIV
levels have also been found to be inversely associated with waist circumference [22].
Our results agree with previous ﬁndings describing a negative correlation between
DPPIV activity and increased body fat mass [3]. It is notable that our study, and
others showing negative associations between obesity parameters and DPPIV,
have been performed in apparently healthy populations [3, 22], while most studies
showing positive correlations analyzed obese or diabetic subjects [10, 11, 12, 13].
In addition, the study by Neidert and coworkers [3] and the present research
analyzed enzyme activity instead of protein concentration.
DPPIV is a ‘moonlighting’ glycosylated protein whose enzymatic activity can have a
variety of eﬀects. Its multifunctional activity depends on cell type and intracellular
conditions that inﬂuence its role as a proteolytic enzyme, cell surface receptor, costi-
mulatory interacting protein, or signal transductionmediator [5]. DPPIV degrades en-
domorphin, substance P, neuropeptide Y, insulin-like growth factor I, glucagon-like
peptide 1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP), among
other peptides [4, 7]. Based on its relationship with incretin hormones, previous work
has related DPPIV to BMI, percent of fat mass, and other markers of obesity [13].
However, due to its multiple functions, it is not surprising that there are a variety of
results describing DPPIV serum concentration and enzymatic activity [30].
Regarding physical ﬁtness and taking into account the negative association between
ﬁtness and fatness [31], the positive association between the distance covered inon.2018.e00627
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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obesity parameters. The 6MWT has been described as a simple, safe, and inexpensive
sub-maximal exercise test [32], is a good marker of cardio respiratory ﬁtness, and is
suggested as a powerful predictor of survival for patients in clinical settings [33].
The number of CPMs is an indicator of total physical activity [34]. Thus, the pos-
itive association of the number of CPMs and time spent in light activity with
sDPPIV activity allows us to conclude that higher rates of sDPPIV activity are
correlated with more physical activity. Obesity and sedentary habits are indicators
of cardiovascular risk [35], while the opposite is true for greater time spent in phys-
ical activity [36].
Variations in the concentration of sDPPIV linked to physical exercise and/or ﬁtness
could be related to the recently described auto/paracrine as well as endocrine eﬀects
of DPPIV as a myokine on organs such as liver, adipose tissue, and bone [37]. Based
on our ﬁndings, sDPPIV activity is likely to be positively tied to exercise, and as a
result, with cardiorespiratory and muscular health. This highlights the fact that exer-
cise induces expression of some myokines but not all [37]. However, its role is far
from clear as others have described a reduction in plasma DPPIV concentration after
body mass loss or exercise training [11]. The diﬀerent populations analyzed in both
studies e apparently healthy individuals vs. subjects with metabolic syndrome e
could be the reason for this discrepancy.
It is notable that there are sex-related diﬀerences in the interaction among adiposity,
age, and cardiovascular risk, with the latter being more aﬀected by age in women
than in men. The activity of other peptidases related to cardiovascular risk has
also been described previously as being dependent upon sex and age [21]. These re-
sults suggest that peptidases could be involved in the relationship between sex, age,
and cardiovascular risk.
Several authors have described the lack of knowledge about the mechanism of
DPPIV metabolism regulation in vivo [8]. Our results suggest that more complex
analysis should be performed to clarify the role of DPPIV in obesity, physical ﬁtness,
and physical activity, as well as the pathways that regulate the balance between the
enzymatically active and the inactive protein. Due to variations in DPPIV depending
on cell type and intracellular or extracellular conditions that inﬂuence the role of
DPPIV, it has been proposed as a therapeutic target in pathologic conditions such
as diabetes [7].
In addition to the multifunctionality of DPPIV, other factors could explain the vari-
ation in studies relating this protein to obesity and health. Anthropometric character-
istics, health status, ethnicity [3], lifestyle, and genetic characteristics could play a
role in the relationship between BMI and DPPIV activity [1]. Several studies
describe Asian obese patients [10, 38] and most have been carried out analyzingon.2018.e00627
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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focused on sDPPIV activity in an apparently healthy Caucasian population and is in
agreement with studies carried out in non-obese subjects. Nonetheless, the complex
regulation pathways of DPPIV, the mechanism of its release from the plasma mem-
brane, and its kinetics remain poorly understood, and further studies are needed to
clarify the multiple functions and roles of DPPIV [2, 23].
The main limitation of this study is that due to its cross-sectional nature, causality
cannot be inferred from our results. We have also to take into account that here pre-
sented results belonged to a healthy population; therefore these results cannot be
directly extrapolated to obese people or individual pathologies. Another possible
limitation of this study is that accelerometers do not capture exercises such as swim-
ming and other aquatic sports. However, despite this limitation, the greater accuracy
and precision of its use is well established in relation to the collection of data on
physical activity through self-report questionnaires. In contrast, this study has impor-
tant strengths. One is the bigger sample size than other studies analyzing the asso-
ciation between DPPIV and obesity. In addition, the majority of previous works
describing DPPIV only presented the relationship between DPPIV and parameters
related to obesity. However, in the present study, we also analyzed the relationship
of DPPIV and physical ﬁtness and physical activity measured in an objective way.5. Conclusion
In conclusion, serum DPPIV activity not only depends on obesity parameters in
healthy populations, it is also positively tied to some parameters of physical ﬁtness
and physical activity. In addition, sex and age related diﬀerences in sDPPIV activity
have been found. Due to controversial results about the concentration of DPPIV and
its enzymatic activity related to obesity and exercise, further investigations should
seek to clarify the regulation and metabolism of this myokine with the purpose of
enhancing its use as biomarker.Declarations
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